about
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and i...
Read More
50.62
0.06
(0.12%)
5.2M
XNYS Volume
XNYS 07 Jan, 2026 4:30 PM (EST)
Analyst Downgrade
Barclays downgrades GSK to an 'Underweight' rating; cites lack of significant upcoming clinical trials
See details
Medium Financial Strength
Mid Valuation
Technically Moderately Bullish
Turnaround Potential
These stocks have average financials and valuation, but strong momentum indicating buying interest
View Similar
Embed DVM
GSK PLC (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..